Ashley Cordova is Chief Financial Officer of NovoCure Ltd. Currently has a direct ownership of 219,867 shares of NVCR, which is worth approximately $3.77 Million. The most recent transaction as insider was on Feb 27, 2024, when has been sold 102,249 shares (Ordinary Shares) at a price of $16.3 per share, resulting in proceeds of $1,666,658. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K
0% 3M change
117.02% 12M change
Total Value Held $3.77 Million

Ashley Cordova Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2024
BUY
Grant, award, or other acquisition
$1,666,658 $16.3 p/Share
102,249 Added 31.74%
219,867 Ordinary Shares
Nov 02 2023
BUY
Exercise of conversion of derivative security
$2,005 $11.46 p/Share
175 Added 0.15%
117,618 Ordinary Shares
Oct 31 2023
BUY
Exercise of conversion of derivative security
$178,285 $10.02 p/Share
17,793 Added 13.16%
117,443 Ordinary Shares
Sep 01 2023
SELL
Open market or private sale
$19,267 $21.82 p/Share
883 Reduced 0.88%
99,650 Ordinary Shares
Aug 02 2023
SELL
Open market or private sale
$34,606 $30.25 p/Share
1,144 Reduced 1.13%
100,533 Ordinary Shares
Jun 30 2023
BUY
Grant, award, or other acquisition
$12,947 $35.28 p/Share
367 Added 0.36%
101,677 Ordinary Shares
Mar 03 2023
SELL
Open market or private sale
$419,260 $76.16 p/Share
5,505 Reduced 5.15%
101,310 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
-
11,808 Added 9.95%
106,815 Ordinary Shares
Mar 02 2023
SELL
Open market or private sale
$79,420 $75.28 p/Share
1,055 Reduced 1.1%
95,007 Ordinary Shares
Mar 01 2023
SELL
Open market or private sale
$167,839 $76.36 p/Share
2,198 Reduced 2.24%
96,062 Ordinary Shares
Feb 28 2023
BUY
Grant, award, or other acquisition
-
23,818 Added 19.51%
98,260 Ordinary Shares
Jan 06 2023
BUY
Grant, award, or other acquisition
$4,111 $62.3 p/Share
66 Added 0.09%
74,442 Ordinary Shares
Dec 02 2022
BUY
Exercise of conversion of derivative security
$14,300 $7.15 p/Share
2,000 Added 2.62%
74,376 Ordinary Shares
Sep 02 2022
SELL
Open market or private sale
$69,950 $79.04 p/Share
885 Reduced 1.21%
72,376 Ordinary Shares
Aug 02 2022
BUY
Grant, award, or other acquisition
$499,964 $70.2 p/Share
7,122 Added 8.86%
73,261 Ordinary Shares
Jul 05 2022
BUY
Grant, award, or other acquisition
$14,829 $59.08 p/Share
251 Added 0.38%
66,139 Ordinary Shares
Mar 08 2022
SELL
Open market or private sale
$53,206 $70.1 p/Share
759 Reduced 1.23%
60,848 Ordinary Shares
Mar 04 2022
SELL
Open market or private sale
$39,148 $70.41 p/Share
556 Reduced 0.89%
61,607 Ordinary Shares
Mar 03 2022
SELL
Open market or private sale
$85,600 $74.5 p/Share
1,149 Reduced 1.81%
62,163 Ordinary Shares
Mar 03 2022
BUY
Exercise of conversion of derivative security
$68,191 $13.53 p/Share
5,040 Added 7.11%
65,888 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
21,508 Added 25.36%
63,312 Ordinary Shares
Jan 06 2022
BUY
Grant, award, or other acquisition
$2,936 $63.82 p/Share
46 Added 0.11%
41,804 Ordinary Shares
Nov 02 2021
SELL
Open market or private sale
$22,422 $107.28 p/Share
209 Reduced 0.5%
41,758 Ordinary Shares
Sep 02 2021
SELL
Open market or private sale
$114,454 $138.23 p/Share
828 Reduced 1.93%
41,967 Ordinary Shares
Aug 12 2021
SELL
Open market or private sale
$3,752,120 $140.93 p/Share
26,624 Reduced 36.66%
45,993 Ordinary Shares
AC

Ashley Cordova

Chief Financial Officer
Malvern, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Track Activities on NVCR